BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 102 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009 | -43.2% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $3,535 | +167.2% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $1,323 | +5.0% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $1,260 | +26.0% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 700 | -35.1% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 1,079 | +54.1% | 0.00% | – |
| Q2 2021 | $9,000 | -47.1% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | -22.7% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | +23.5% | 700 | +75.0% | 0.00% | – |
| Q2 2020 | $17,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
| NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
| CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
| Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
| Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
| Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
| RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
| Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
| Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |